![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, May 28, 2009 6:49:50 PM
1) They brought it forward for an adult ADHD population first, for a disorder where there is a lot of demand for a nonstimulant option, demand which has allowed a very poor drug, Strattera, to garner $500 million plus in sales per year.
2) The collaboration with Greer was, I believe, signed in summer 07. The ADHD project was 'all in' at that time. If you have a deal--as I have heard--that would have paid $30 million plus upfront, and you don't think that the flaw is inherent to the molecule-- I hear people now saying, with 20:20 hindsight, that they would have dumped the molecule and started again--putting Cortex at least a year behind schedule. I honestly doubt that anyone contributing seriously to this board would actually have made that choice, at the time, based on what was known then. I know I wouldn't have. The same people who say that Cortex should have 'fought' the FDA think that they should have given up on CX717, which is a bizarre combination of confrontation and surrender. The latter had a lot more chance of success than the former.
3) I think Cortex management will take the best deal available, I don't think they would dismiss anything out-of-hand at this point. An indication-based deal, a low impact platform deal, a buyout, I believe they are all on the table.
NeuroInvestment
Recent RSPI News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 12:30:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 08:01:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 01:03:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 01:30:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:45:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:45:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:06:03 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:05:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 01:00:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 12:45:26 PM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM